טוען...
Bone Marrow Mesenchymal Stem Cell Administration Significantly Improves Outcome after Retinal Ischemia in Rats
PURPOSE: Ischemia-associated retinal degeneration is one of the leading causes of vision loss and to date, there are no effective treatment options. We hypothesized that delayed injection of bone marrow stem cells (BMSCs) 24 h after the onset of ischemia could effectively rescue ischemic retina from...
שמור ב:
| הוצא לאור ב: | Graefes Arch Clin Exp Ophthalmol |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5841582/ https://ncbi.nlm.nih.gov/pubmed/28523456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00417-017-3690-1 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|